Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001289996 | SCV001603278 | likely benign | Tumor predisposition syndrome 3 | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002375332 | SCV002667706 | likely benign | Hereditary cancer-predisposing syndrome | 2019-06-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001289996 | SCV001478029 | not provided | Tumor predisposition syndrome 3 | no assertion provided | literature only | A 3.6-fold increase risk for Chronic Lymphocytic Lleukemia reported for individuals with this variant |